SenesTech Ownership
| SNES Stock | USD 5.65 0.03 0.53% |
Shares in Circulation | First Issued 2015-09-30 | Previous Quarter 729.4 K | Current Value 1.3 M | Avarage Shares Outstanding 155.6 K | Quarterly Volatility 398.6 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
SenesTech | Build AI portfolio with SenesTech Stock |
SenesTech Stock Ownership Analysis
The company recorded a loss per share of 6.58. SenesTech last dividend was issued on the 5th of February 2020. The entity had 1:10 split on the 25th of July 2024. SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona. Senestech operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. To find out more about SenesTech contact Joel Fruendt at 928 779 4143 or learn more at https://www.senestech.com.SenesTech Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as SenesTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SenesTech backward and forwards among themselves. SenesTech's institutional investor refers to the entity that pools money to purchase SenesTech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2025-03-31 | 5.3 K | Advisor Group Holdings, Inc. | 2025-03-31 | 2.8 K | Banque Transatlantique | 2025-03-31 | 445 | Bank Of America Corp | 2025-03-31 | 8.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | Sabby Management Llc | 2024-12-31 | 0.0 | Tower Research Capital Llc | 2025-03-31 | 0.0 |
SenesTech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SenesTech insiders, such as employees or executives, is commonly permitted as long as it does not rely on SenesTech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SenesTech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
SenesTech Outstanding Bonds
SenesTech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SenesTech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SenesTech bonds can be classified according to their maturity, which is the date when SenesTech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| SENMED 2927 01 NOV 51 Corp BondUS81728XAA63 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| ST 5875 01 SEP 30 Corp BondUS81725WAL72 | View | |
| US81725WAK99 Corp BondUS81725WAK99 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| SENIOR HSG PPTYS Corp BondUS81721MAM10 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
SenesTech Corporate Filings
| 18th of July 2025 Other Reports | ViewVerify | |
| 14th of July 2025 Other Reports | ViewVerify | |
| 11th of July 2025 Other Reports | ViewVerify | |
8K | 10th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SenesTech Stock Analysis
When running SenesTech's price analysis, check to measure SenesTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenesTech is operating at the current time. Most of SenesTech's value examination focuses on studying past and present price action to predict the probability of SenesTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenesTech's price. Additionally, you may evaluate how the addition of SenesTech to your portfolios can decrease your overall portfolio volatility.